Auragens’ Commitment to Transparency and Innovation
At Auragens, we recognize the critical importance of advancing stem cell treatment research and sharing our findings through medical journals. Our goal in authoring and widely disseminating these journals is to provide transparency and insight into the latest developments in mesenchymal stem cell and exosome treatments. Our dedicated team remains at the forefront of scientific advancements, and we are excited to share our expertise with the world. By offering this knowledge, we aim to empower individuals to make informed decisions about their health and well-being.
Published Articles
July 10, 2024
July 16, 2025
May 19, 2024
May 14, 2024
Erector Spinae Infiltration With Mesenchymal Stromal Cells In Chronic Lumbar Pain: A Case Report Series
Chronic lumbar pain associated to multiple conditions including discopathy and facet arthropathy can significantly impact a patient’s quality of life requiring innovative treatment approaches that are safe, effective, and sustainable. This case study evaluates the safety and efficacy of regenerative medicine biologic products in the form of human umbilical cord Wharton’s Jelly derived mesenchymal stromal cells (hUC-MSC) and exosomes delivered intravenously and locally via erector spinae plane (ESP) block, for the relief of chronic lumbar pain.
MSC-Based Biological Enhancement for Radiation Exposure Leveraging MSCs for Enhanced Radiation Resistance
The exploration and planned habitation of Mars present formidable challenges due to the planet’s harsh environment, particularly the high levels of cosmic radiation resulting from its thin atmosphere and lack of a global magnetic field. Cosmic radiation poses severe health risks to astronauts, including acute radiation syndrome, increased cancer risk, and damage to vital organ systems. Current protective measures, such as physical shielding incorporated into spacecraft and habitats, are insufficient for long-term missions and extended extravehicular activities, necessitating innovative solutions to enhance human resistance to radiation.
Age-Related KLHL22 Expression in Human MSCs and Regenerative Implications
Aging in human bone marrow-derived mesenchymal stromal cells (hMSCs) affects their regenerative capabilities and therapeutic efficacy, which are critical for successful cell-based regeneration therapies. In this study, we aimed to identify genetic markers of aging in hMSCs to better understand the impact of donor age on cell function.
The goal of this article is to provide NBA physical therapists with a scientifically grounded, ethical, and practical overview of stem cell therapies. Our hope is that, with a stronger foundation of education, stem cell therapies can become part of the initial conversations that occur in training rooms following acute injuries, surgeries, or during recovery planning.
FOSL2 Gene Expression Declines with Age in Bone Marrow-derived MSCs
The FOSL2 gene, integral to the AP-1 transcription factor complex, orchestrates cellular responses to stimuli, including immune surveillance and tissue-resident memory T cell differentiation. This study investigates FOSL2’s expression dynamics across ages to elucidate its role in aging and age-associated diseases.
NEW YORK, NY, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Dr. Dan Briggs, President and CEO of Auragens, was recently selected as Top Medical Researcher of the Year for 2025 by the International Association of Top Professionals (IAOTP) for his outstanding leadership, dedication, and commitment to the industry.
